Scott W Harden - Medical Status

Scott underwent an allogenic bone marrow transplant to treat relapsed peripheral T-cell lymphoma in mid-2026. Complications (heart and kidney failure) forced Scott to stop using the computer completely June through September. Scott is still recovering and only using the computer for limited purposes at this time.

Updated: 2026-09-24

Timeline

  • 2026 Sep: Bone marrow transplant complete!
  • 2026 Jun: Allogenic bone marrow transplant
    • Pre-transplant chemo: fludarabine and melphalan
    • Transplant: 2026-06-25
    • Post-transplant chemo: cyclophosphamide
    • Complications: Heart and Kidney failure
    • Stayed in hospital for over 50 days (over 30 in ICU)
  • 2026 May: PET CT indicates remission
  • 2026 Apr: Chemotherapy: ifosfamide, carboplatin, etoposide
  • 2026 Feb: Chemotherapy: duvelisib and romidepsin (aborted due to HLH reaction)
  • 2025 Dec: Antibody therapy: anti-CD94 (aborted due to incomplete response)
  • 2025 Nov: Relapse identified via CT and confirmed with surgery
  • 2019: Treatments considered successful. Stable health for 6 years.
  • 2019: Autologous bone marrow transplant
  • 2019: Radiation therapy
  • 2018: Chemotherapy: cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP, 5 rounds)
  • 2018: Indolent disease became aggressive
  • 2012: Diagnosed with Peripheral T-Cell Lymphoma

Photos

How Can I Help?

Impact on Open Source Projects

Miscellaneous